Table 3 |
||||||||
|
Mean escape latency time (ELT) calculated for each day during acquisition trials and day 4 ELT was used as an index of acquisition |
||||||||
|
Day1 |
Q1 |
Q2 |
Q3 |
Q4 |
||||
|
Day2 |
Q2 |
Q3 |
Q4 |
Q1 |
||||
|
Day3 |
Q3 |
Q4 |
Q1 |
Q2 |
||||
|
Day4 |
Q4 |
Q1 |
Q2 |
Q3 |
||||
|
|
||||||||
|
Koladiya et al. BMC Pharmacology 2008 8:14 doi:10.1186/1471-2210-8-14 |
||||||||